EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Decoding the lymphangioleiomyomatosis niche microenvironment via integrative analysis of single cell multiomics and spatial transcriptomics

Ken Chen iD, Shuyang Zhao iD, Minzhe Guo, Hasan Reza, Andrew Wagner, Adnan Cihan Cakar, Cheng Jiang, Erik Zhang, Jenna Green, Emily P Martin, Grace A Wikenheiser, Kathryn A Wikenheiser-Brokamp und 4 weitere

European Respiratory Journal · 2026-11 · 68 (5) · 2502049

DOI: 10.1183/13993003.02049-2025 ↗

Kurz gefasst

Fachartikel in der Zeitschrift European Respiratory Journal, online erschienen am 25.06.2026. Verfasst von Ken Chen und 15 weiteren Autor:innen. Beteiligte Einrichtung: The Perinatal Institute and Section of Neonatology, Perinatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, U…. Hauptthemen laut MEDLINE: Lymphangioleiomyomatosis, Tumor Microenvironment. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NHLBI NIH HHS, National Heart, Lung, and Blood Institute, LAM Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Lymphangioleiomyomatosis (LAM) is a rare, destructive lung disease caused by mutations in tuberous sclerosis complex 1 (TSC1) or TSC2, leading to mammalian target of rapamycin complex 1 (mTORC1) hyperactivation. While mTOR inhibitor sirolimus, the only US Food and Drug Administration approved drug for this disease, stabilises lung function in most LAM patients, the drug does not eliminate LAM cells, underscoring a critical gap in our understanding of the tumour microenvironment and cellular heterogeneity that drive disease progression. This study provides the first comprehensive multiomics atlas of the human LAM niche, integrating single-cell/single-nucleus RNA-sequencing, single-nucleus ATAC-sequencing, and spatial transcriptomics to deconvolute its complex architecture. We elucidate LAM cellular heterogeneity by identifying three distinct subtypes: the canonical, uterine smooth muscle-like, mTORC1-hyperactive LAM CORE1 ; a novel, fibroblast-like LAM CORE2 subtype with potent extracellular matrix (ECM) remodelling activity; and LAM CORE3 , a substate of LAM CORE1 that shares LAM and myogenic signatures, but is characterised by lower transcriptional activity and specific functional enrichment in protein translation. Our analysis reveals the transcriptomic heterogeneity of the LAM subtypes, orchestrated by distinct transcriptional drivers and networks. Furthermore, we uncover spatially resolved LAM-associated fibroblast (LAF) states, LAF-seed and LAF-niche, that coordinate transforming growth factor-β signalling, ECM deposition and remodelling, and niche expansion. Spatial mapping uncovers a structured ecosystem where LAM CORE1 cells form a central core enmeshed with the lymphatic endothelium, which is surrounded by LAFs, LAM CORE2 cells, and reprogrammed immune and epithelial cells. Findings were validated through multimodal imaging technologies. Present work advances the field by providing the first high-resolution blueprint of the LAM niche microenvironment, revealing novel cell states and crosstalk that identify promising novel therapeutic targets.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LymphangioleiomyomatosisTumor MicroenvironmentHumansSpatial TranscriptomicsMultiomicsSingle-Cell AnalysisExtracellular MatrixMechanistic Target of Rapamycin Complex 1TranscriptomeFemaleSirolimus

Substanzen

Mechanistic Target of Rapamycin Complex 1Sirolimus

Autor:innen und Institutionen

  • The Perinatal Institute and Section of Neonatology, Perinatal and Pulmonary Biology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH, USA.
  • Department of Plant and Microbial Biology, University of California, Berkeley, CA, USA.
  • Contributed equally to the work as first authors.
  • Department of Pediatrics, University of Cincinnati School of Medicine, Cincinnati, OH, USA.
  • Institute of Clinical and Translational Research, Vanderbilt University Medical Center, Nashville, TN, USA.
  • Division of Pulmonary, Critical Care and Sleep Medicine, University of Cincinnati School of Medicine, Cincinnati, OH, USA.

ORCID-Profile: Ken Chen, Shuyang Zhao

Förderung

  • NHLBI NIH HHS
  • National Heart, Lung, and Blood Institute
  • LAM Foundation

Zitieren

APA

Chen, K., Zhao, S., Guo, M., Reza, H., Wagner, A., Cakar, A. C., Jiang, C., Zhang, E., Green, J., Martin, E. P., Wikenheiser, G. A., Wikenheiser-Brokamp, K. A., Perl, A. K., Sinner, D., Yu, J. J., & Xu, Y. (2026). Decoding the lymphangioleiomyomatosis niche microenvironment via integrative analysis of single cell multiomics and spatial transcriptomics. European Respiratory Journal, 68(5), 2502049. https://doi.org/10.1183/13993003.02049-2025

Vancouver

Chen K, Zhao S, Guo M, Reza H, Wagner A, Cakar AC, et al. Decoding the lymphangioleiomyomatosis niche microenvironment via integrative analysis of single cell multiomics and spatial transcriptomics. European Respiratory Journal. 2026;68(5):2502049. doi:10.1183/13993003.02049-2025

BibTeX
@article{Chen2026,
  author = {Chen, Ken and Zhao, Shuyang and Guo, Minzhe and Reza, Hasan and Wagner, Andrew and Cakar, Adnan Cihan and Jiang, Cheng and Zhang, Erik and Green, Jenna and Martin, Emily P and Wikenheiser, Grace A and Wikenheiser-Brokamp, Kathryn A and Perl, Anne Karina and Sinner, Debora and Yu, Jane J and Xu, Yan},
  title = {Decoding the lymphangioleiomyomatosis niche microenvironment via integrative analysis of single cell multiomics and spatial transcriptomics},
  journal = {European Respiratory Journal},
  year = {2026},
  volume = {68},
  number = {5},
  pages = {2502049},
  doi = {10.1183/13993003.02049-2025}
}
Kostenlos starten →